STIVARGA: Bayer says its Stivarga improved overall survival in liver cancer in latestage trials

German pharma and crop sciences giant Bayer ETR BAYN said latestage trials for its drug to treat liver cancer showed a median overall survival.The company said the study showed Stivarga had a median overall survival of 10.6 months versus 7.8 months for pla...